These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25822291)

  • 1. Primary definitive radiotherapy with or without chemotherapy for squamous cell carcinoma of the temporal bone.
    Kitani Y; Kubota A; Furukawa M; Sato K; Nakayama Y; Nonaka T; Mizoguchi N
    Eur Arch Otorhinolaryngol; 2016 May; 273(5):1293-8. PubMed ID: 25822291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five-year outcomes of squamous cell carcinoma of the tonsil treated with radiotherapy.
    Mourad WF; Hu KS; Puckett L; Hauerstock D; Shourbaji RA; Li Z; Manolidis S; Schantz S; Tran T; Jacobson A; Urken M; Culliney B; Persky M; Harrison LB
    Am J Clin Oncol; 2014 Feb; 37(1):57-62. PubMed ID: 23357967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoradiotherapy followed by consolidation chemotherapy involving paclitaxel and carboplatin and in FIGO stage IIIB/IVA cervical cancer patients.
    Mabuchi S; Isohashi F; Okazawa M; Kitada F; Maruoka S; Ogawa K; Kimura T
    J Gynecol Oncol; 2017 Jan; 28(1):e15. PubMed ID: 27958682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triple-modality treatment in patients with advanced stage tonsil cancer.
    Roden DF; Schreiber D; Givi B
    Cancer; 2017 Sep; 123(17):3269-3276. PubMed ID: 28440876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can concurrent chemoradiotherapy replace surgery and postoperative radiation for locally advanced stage III/IV tonsillar squamous cell carcinoma?
    Park G; Lee SW; Kim SY; Nam SY; Choi SH; Kim SB; Roh JL; Yoon DH; Kim SS; Park JH; Kim YS; Yoon SM; Song SY; Kim JH; Choi EK; DO Ahn S
    Anticancer Res; 2013 Mar; 33(3):1237-43. PubMed ID: 23482808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent chemoradiotherapy with paclitaxel and nedaplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: preliminary results of a phase II study.
    Zhang MQ; Liu SP; Wang XE
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):821-7. PubMed ID: 20207507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent chemoradiotherapy with cisplatin and fluorouracil for locally advanced hypopharyngeal carcinoma.
    Yoon MS; Chung WK; Ahn SJ; Nam TK; Nah BS; Song JY; Lim SC; Lee JK
    Acta Otolaryngol; 2008 May; 128(5):590-6. PubMed ID: 18421617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction chemotherapy followed by concurrent chemoradiotherapy vs. concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study.
    Zhang J; Chen S; Li G; Zhang W; Qin T; Yin P; Huang H; Jiang H
    Cancer Chemother Pharmacol; 2017 Jun; 79(6):1087-1097. PubMed ID: 28429051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment results and prognostic factors for advanced squamous cell carcinoma of the larynx treated with concurrent chemoradiotherapy.
    Taguchi T; Nishimura G; Takahashi M; Komatsu M; Sano D; Sakuma N; Arai Y; Yamashita Y; Shiono O; Hirama M; Sakuma Y; Ishitoya J; Hata M; Ogino I; Oridate N
    Cancer Chemother Pharmacol; 2013 Oct; 72(4):837-43. PubMed ID: 23959463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of pretreatment carcinoembryonic antigen after definitive radiotherapy with or without concurrent chemotherapy for squamous cell carcinoma of the uterine cervix.
    Huang EY; Hsu HC; Sun LM; Chanchien CC; Lin H; Chen HC; Tseng CW; Ou YC; Chang HY; Fang FM; Huang YJ; Wang CY; Lu HM; Tsai CC; Ma YY; Fu HC; Wang YM; Wang CJ
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1105-13. PubMed ID: 20932670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the clinicopathological features of squamous cell carcinoma of the vulva: a retrospective survey of the Tohoku Gynecologic Cancer Unit.
    Futagami M; Yokoyama Y; Iino K; Aoki M; Shoji T; Sugiyama T; Ariga H; Tokunaga H; Takano T; Watanabe Y; Yaegashi N; Jingu K; Sato N; Terada Y; Anbai A; Ohta T; Kurachi H; Kuroda Y; Nishiyama H; Fujimori K; Watanabe T; Sato H; Tase T; Wada H; Mizunuma H
    Int J Clin Oncol; 2015 Oct; 20(5):1005-11. PubMed ID: 25708593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Definitive radiotherapy for early-stage hypopharyngeal squamous cell carcinoma.
    Sato K; Kubota A; Furukawa M; Kitani Y; Nakayama Y; Nonaka T; Mizoguchi N; Shiomi M
    Eur Arch Otorhinolaryngol; 2015 Aug; 272(8):2001-6. PubMed ID: 24939176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Concurrent chemoradiotherapy followed by consolidation chemotherapy and sequential chemoradiotherapy for stage III non-small cell lung cancer: comparison in 93 patients].
    Sun WZ; Song LP; Zhang YB; Ai T; Lu JL; Ren J; Gao Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Mar; 32(3):362-7. PubMed ID: 22445984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment outcome of advance staged oral cavity cancer: concurrent chemoradiotherapy compared with primary surgery.
    Tangthongkum M; Kirtsreesakul V; Supanimitjaroenporn P; Leelasawatsuk P
    Eur Arch Otorhinolaryngol; 2017 Jun; 274(6):2567-2572. PubMed ID: 28321535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment outcomes between concurrent chemoradiotherapy and combination of surgery, radiotherapy, and/or chemotherapy in stage III and IV maxillary sinus cancer: multi-institutional retrospective analysis.
    Kang JH; Cho SH; Kim JP; Kang KM; Cho KS; Kim W; Seol YM; Lee S; Park HS; Hur WJ; Choi YJ; Oh SY
    J Oral Maxillofac Surg; 2012 Jul; 70(7):1717-23. PubMed ID: 21945430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Squamous cell carcinoma of temporal bone: reported on 33 patients.
    Zhang B; Tu G; Xu G; Tang P; Hu Y
    Head Neck; 1999 Aug; 21(5):461-6. PubMed ID: 10402528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of concurrent chemoradiotherapy at the dose of 50.4 Gy with elective nodal irradiation for Stage II-III esophageal carcinoma.
    Kato K; Nakajima TE; Ito Y; Katada C; Ishiyama H; Tokunaga SY; Tanaka M; Hironaka S; Hashimoto T; Ura T; Kodaira T; Yoshimura K
    Jpn J Clin Oncol; 2013 Jun; 43(6):608-15. PubMed ID: 23585687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of definitive concurrent chemoradiotherapy for vulvar cancer: a Japanese Gynecologic Oncology Group nationwide survey study.
    Okonogi N; Tsuchida K; Ando K; Ohno T; Fujiwara H; Yoshihara K; Aoki T; Takano H; Takekuma M; Okamoto A; Nishio S
    Jpn J Radiol; 2024 Jul; 42(7):777-784. PubMed ID: 38568430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a benefit in receiving concurrent chemoradiotherapy for elderly patients with inoperable thoracic esophageal squamous cell carcinoma?
    Zhang P; Xi M; Zhao L; Shen JX; Li QQ; He LR; Liu SL; Liu MZ
    PLoS One; 2014; 9(8):e105270. PubMed ID: 25133495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective analysis of outcome differences in preoperative concurrent chemoradiation with or without elective nodal irradiation for esophageal squamous cell carcinoma.
    Hsu FM; Lee JM; Huang PM; Lin CC; Hsu CH; Tsai YC; Lee YC; Chia-Hsien Cheng J
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e593-9. PubMed ID: 21658851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.